AKT1 and non-small cell lung carcinoma: Moreover, MALAT1 is involved in the upregulation of BCL2, MMP9, PIK3CA expressions, thus activating the PI3K/AKT signaling pathway in NSCLC tumor tissues and H1299 cell lines [77].